Inventor · disambiguated record
Dansu Li
Also filed as: LI DANSU
36 granted patents·6 pending applications·249 citations·filing 2005–2024
97Inventor score
Files withUNIV CORNELL10SCHERING CORP8SYROS PHARMACEUTICALS INC6YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD5MERCK SHARP & DOHME2
Top patents by PatentIndex Score
42 records- 0196US10961218B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2020·Granted Mar 30, 2021·4 cites·24 claims
- 0295US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0394US10745379B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2018·Granted Aug 18, 2020·7 cites·24 claims
- 0493US11649224B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2021·Granted May 16, 2023·2 cites·18 claims
- 0592US10059690B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2017·Granted Aug 28, 2018·9 cites·19 claims
- 0692US8178553B2Compounds for the treatment of inflammatory disordersLAVEY BRIAN J·Filed 2010·Granted May 15, 2012·46 cites·19 claims
- 0792US7524842B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Apr 28, 2009·19 cites·34 claims
- 0892US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0991US8569336B2Compounds for the treatment of inflammatory disordersTONG LING·Filed 2009·Granted Oct 29, 2013·44 cites·4 claims
- 1090US11021466B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2019·Granted Jun 1, 2021·3 cites·18 claims
- 1188US11634403B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2021·Granted Apr 25, 2023·1 cites·22 claims
- 1288US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 1387US10960003B2Pyrazole pyrimidine derivative and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2019·Granted Mar 30, 2021·4 cites·20 claims
- 1487US10376511B2Pyrazole pyrimidine derivative and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2016·Granted Aug 13, 2019·10 cites·39 claims
- 1586US10308648B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Jun 4, 2019·6 cites·20 claims
- 1686US7772263B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Granted Aug 10, 2010·7 cites·31 claims
- 1786US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 1886US2024425477A1Ire1 small molecule inhibitorsUNIV CORNELL·Filed 2024·Application pending·0 cites
- 1985US11072599B2Pyrazole compounds and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2018·Granted Jul 27, 2021·4 cites·25 claims
- 2085US10106526B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2015·Granted Oct 23, 2018·5 cites·19 claims
- 2184US12071424B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2023·Granted Aug 27, 2024·0 cites·21 claims
- 2284US10519135B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·3 cites·18 claims
- 2382US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 2479US10865206B2Inhibitors of cyclin-dependent kinase 7 (CDK7)SYROS PHARMACEUTICALS INC·Filed 2019·Granted Dec 15, 2020·1 cites·25 claims
- 2574US7683088B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Mar 23, 2010·1 cites·19 claims
- 2672US8541572B2Compounds for the treatment of inflammatory disordersKOZLOWSKI JOSEPH A·Filed 2009·Granted Sep 24, 2013·2 cites·4 claims
- 2770US9624208B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·1 cites·5 claims
- 2870US9586968B2Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2014·Granted Mar 7, 2017·2 cites·19 claims
- 2969US11925641B2Pyrazole pyrimidine derivative and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Granted Mar 12, 2024·0 cites·19 claims
- 3068US10392367B2IRE1 small molecule inhibitorsQUENTIS THERAPEUTICS INC·Filed 2018·Granted Aug 27, 2019·1 cites·29 claims
- 3165US2021061803A1Inhibitors of cyclin-dependent kinase 7 (cdk7)SYROS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3262US11999721B2Pyrazole compounds and uses thereofYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2021·Granted Jun 4, 2024·0 cites·24 claims
- 3362US9273040B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsLAYTON MARK E·Filed 2012·Granted Mar 1, 2016·1 cites·22 claims
- 3462US2025243220A1Atr inhibitorsAPREA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3552US12479818B2Treatment of fibrosis with IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2020·Granted Nov 25, 2025·0 cites·20 claims
- 3652US2022265656A1Combination therapies with ire1 small molecule inhibitorsUNIV CORNELL·Filed 2020·Application pending·0 cites
- 3750US2018346446A1Ire1 small molecule inhibitorsQUENTIS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3845US8450355B2Compounds for the treatment of inflammatory diseasesWONG MICHAEL K C·Filed 2009·Granted May 28, 2013·0 cites·19 claims
- 3943US8859529B2Compounds for the treatment of inflammatory disordersSHANKAR BANDARPALLE B·Filed 2009·Granted Oct 14, 2014·0 cites·16 claims
- 4041US10934275B2IRE1 small molecule inhibitorsUNIV CORNELL·Filed 2017·Granted Mar 2, 2021·0 cites·25 claims
- 4138US2017158702A1Multivalent ras binding compoundsKYRAS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4236US9242995B2Isoxazolopyridine orexin receptor antagonistsLI DANSU·Filed 2012·Granted Jan 26, 2016·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Dansu Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →